Delivery Order SPE2DB20D3101-SPE2DB24FRPV7
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $16,818.10 and is a Firm Fixed Price Delivery Order that runs through September 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under a larger Indefinite Delivery Contract (IDC), is for the supply of dapagliflozin 10 mg tablets, a medication used to treat diabetes. The award has a ceiling value of $5,518.03 and a period of performance through January 28, 2025. The contract is a Firm Fixed Price arrangement and does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,992.41 Firm Fixed Price Delivery Order is for the supply of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,166.68 contract is for the delivery of dapagliflozin 10 mg tablets, a medication used to manage diabetes. The ultimate completion date is November 14, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,855.89 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 19, 2024 and was awarded on September 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of dapagliflozin 10 mg tablets. The contract has a ceiling value of $15,557.59 and a completion date of December 13, 2024. It was awarded on December 12, 2024 as a firm fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures medical supplies and equipment.
The contract is not...
This federal contract award, valued at $24,943.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566999548 DAPAGLIFLOZIN 10 MG TABLET 30S, a drug used for the treatment of diabetes.
The contract has an ultimate completion date of January 22, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $2,001.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,067.27, is for the delivery of dapagliflozin 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,471.44 firm fixed-price delivery order is for the supply of Dapagliflozin 5 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024.
This award is associated with a larger Indefinite Delivery Contract (IDC)...